Supplementary Table S12 from TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy

Read full text Summarise with VIRAT
Authors: Evelyn De Tavernier, Peter S. Kim, Eduardo M. Bruch, Virna F. Cortez-Retamozo, Lien Timmerman, Alyssa L. Flynn, Wouter Van Overbeke, Fabrice Tirode, Valeria Cintra Barbosa-Lorenzi, Peter A. Piepenhagen, Thuvan Dinh-Le, Ernesto Luna
+5 more Aiqun Li, Ann Baker, Alexey Rak, Lily I. Pao, Ana Paula B. Vintém
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Supplementary Table S12 shows mean pharmacokinetic parameters of TPP-45131 in a non-clinical exploratory NHP study (n = 2)

Fields of Study & Subjects

Monoclonal and Polyclonal Antibodies Research HER2/EGFR in Cancer Research Cancer Immunotherapy and Biomarkers

Publication details

Publication date
2 April 2026
Language
EN